Viewing Study NCT04843592


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2025-12-30 @ 5:25 AM
Study NCT ID: NCT04843592
Status: COMPLETED
Last Update Posted: 2021-04-13
First Post: 2021-04-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SOKARY Mobile Application With Type II Diabetes
Sponsor: Magda Bayoumi
Organization:

Study Overview

Official Title: Effectiveness of Using SOKARY Mobile Application on Compliance of Patient With Type II Diabetes: A Quasi- Experimental Study
Status: COMPLETED
Status Verified Date: 2019-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DM
Brief Summary: Android mobile application named (SOKARY)
Detailed Description: Android mobile application named (SOKARY) which means diabetes was selected as an example of mobile health application as it has the advantage of Arabic interface, free use it allows users to record his/their blood glucose level, nutrition and physical activity, then provide the user with statistics for those readings. The application also sends notifications to the users such as medication reminders and healthy lifestyle advice.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: